Who Owns CUE?

Cue Biopharma, Inc. — Institutional Ownership & 13F Holdings

$14.94

+1.94 (+14.92%)

Market Cap

$47.1M

Shares Outstanding

2,627,928

Institutional Holders

49

Total Inst. Value

$19.5M

% of Float Held

14.6%

QoQ Holder Change

-16

Institutional data as of Q1 2025

New Positions

8

Closed Positions

14

Increased

8

Decreased

13

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$9.1M10,000
2Bleichroeder LP$4.6M4,997,240
3VANGUARD GROUP INC$2.1M2,315,862
4GEODE CAPITAL MANAGEMENT, LLC$631K693,890
5BlackRock, Inc.$579K635,203
6Robertson Stephens Wealth Management, LLC$436K478,500
7Sigma Planning Corp$297K326,260
8BANK OF AMERICA CORP /DE/$295K324,351
9ADVISORY RESEARCH INC$234K257,225
10STIFEL FINANCIAL CORP$185K203,578

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold CUE?

As of Q1 2025, 49 institutional investors report holding CUE (Cue Biopharma, Inc.) in their 13F filings.

What percentage of Cue Biopharma, Inc. is owned by institutions?

Institutional investors hold approximately 14.6% of Cue Biopharma, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most CUE?

The largest institutional holder of CUE is NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO with $9.1M in shares.

Are institutions buying or selling CUE?

This quarter, 8 institutions opened new positions in CUE and 14 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.